Act Now to Protect Homeopathic Medicines

The U.S. public is at a pivotal moment in the future of homeopathic medicine. Without prompt congressional action, access to homeopathic medicines could continue to erode under growing regulatory uncertainty.

The Homeopathic Drug Product Safety, Quality and Transparency Act (H.R. 7050) introduced by Pete Sessions and co-sponsored by Jonathan Jackson and Mike Kennedy—offers urgently needed clarity to protect consumer access before more products disappear from the marketplace.

Importantly, this is a bipartisan bill. In today’s polarized political climate, it is rare to see lawmakers from different parties unite around a common-sense health policy solution. Yet H.R. 7050 brings together Republican and Democratic leadership in recognition of a simple principle: Americans deserve safe products, transparent standards, and the freedom to choose the health care options that work for them. Protecting consumer access to homeopathic medicines is not a partisan issue—it is a matter of fairness, regulatory clarity, and respect for patient autonomy.

TAKE ACTION: Tell Congress to Protect Consumer Access to Homeopathic Medicines – Support H.R. 7050!

Homeopathic medicines are used every day in clinical settings by physicians, nurses, dentists, and other licensed professionals. Millions of Americans rely on them as over-the-counter remedies for minor illnesses and injuries. These nontoxic medicines have an unparalleled record of safe use—exceeding the safety record of many conventional drugs and even many common foods. Consumer demand continues to grow as families seek natural, low-risk solutions amid rising chronic disease and persistent health challenges.

Yet despite this long history of safe use, recent actions by the U.S. Food and Drug Administration including the removal of certain homeopathic eye drops and other longstanding remedies have raised serious concerns. Products relied upon for generations have been taken off shelves, creating confusion for consumers and instability for manufacturers and retailers. Many believe these actions reflect a regulatory approach that does not fully account for how homeopathic medicines are formulated, diluted, and traditionally used under recognized standards.

If Congress fails to act, the consequences could be far-reaching. More products may be withdrawn. More manufacturers may exit the market. Retailers may limit availability due to uncertainty. Over time, Americans could see their options steadily reduced—not because of demonstrated safety failures, but because the law lacks clear direction. Once access is lost, it may not be easily restored.

H.R. 7050 provides that direction. It clarifies the role of homeopathic medicines within federal law and establishes standards tailored to their unique characteristics—covering manufacture, labeling, promotion, distribution, and use. It strengthens transparency and quality while ensuring that these products are not forced into a regulatory model designed for entirely different types of drugs. At the same time, it supports a resilient, competitive marketplace by giving suppliers the stability they need to continue serving American consumers.

This bipartisan legislation represents a rare and important opportunity. Lawmakers from both sides of the aisle recognize that consumer choice, safety, and regulatory fairness can—and should—coexist. But that opportunity requires action.

The time to protect access is now. Advancing H.R. 7050 will safeguard consumer rights, preserve marketplace diversity, and ensure that homeopathic medicines remain available to the millions of Americans who depend on them. Without clear congressional leadership, that access could continue to diminish. With bipartisan support already in place, Congress should move swiftly to pass this vital legislation.

TAKE ACTION: Tell Congress to Protect Consumer Access to Homeopathic Medicines – Support H.R. 7050!

Personal Information

First name

Last name

Address

Apt., ste., bldg.

City

State

ZIP Code

I would like to receive weekly Organic Consumers Association News & Action Alerts

*SAMPLE TEXT TO YOUR MEMBERS OF CONGRESS*

You will be able to modify this text on the next page, after entering your information.

Dear [Member of Congress],

We write to express strong support for the Homeopathic Drug Product Safety, Quality and Transparency Act (H.R. 7050), introduced by Pete Sessions. This bipartisan legislation provides long-overdue clarity regarding the role of homeopathic medicines in American health care and ensures continued consumer access to these widely used products.

H.R. 7050 recognizes the unique nature of homeopathic medicines and establishes appropriate standards related to their manufacture, labeling, promotion, distribution, and use. By doing so, it protects consumer rights while maintaining safety, transparency, and accountability in the marketplace.

Importantly, this legislation reflects bipartisan leadership and cooperation. In addition to Rep. Sessions, original co-sponsors include Jonathan Jackson and Mike Kennedy. At a time when bipartisan agreement is rare, this bill stands out as a practical, balanced solution that respects both consumer choice and regulatory integrity.

Recent regulatory actions have underscored the urgent need for statutory clarity. The removal of certain homeopathic eye drops and other longstanding remedies from the marketplace has created confusion and concern among consumers and practitioners. These actions appear to reflect a fundamental misunderstanding within the U.S. Food and Drug Administration regarding how homeopathic medicines are formulated, diluted, and traditionally used under established pharmacopeial standards. Without a regulatory framework that fully accounts for the distinct principles of homeopathy, consumers risk losing access to safe, time-tested products that have been relied upon for generations.

Millions of Americans use homeopathic medicines every day—both under the guidance of licensed health care professionals and as over-the-counter options for minor illnesses and injuries. Physicians, nurses, dentists, and other providers incorporate these nontoxic products into clinical practice. Consumers increasingly seek natural and complementary approaches as they navigate rising rates of chronic disease and ongoing health challenges.

Absent clear congressional direction, continued regulatory uncertainty could further erode access, limit marketplace diversity, and reduce patient choice. H.R. 7050 fosters a resilient and competitive supply chain while reinforcing safety and quality standards tailored to the unique characteristics of homeopathic medicines. It protects Americans’ right to make informed decisions about their health and ensures continued access to the full range of homeopathic products.

We respectfully urge you to support and advance H.R. 7050. Protecting consumer access, preserving health care freedom, and reinforcing bipartisan cooperation are goals that transcend party lines and serve the best interests of the U.S. public.

Sincerely,

[Your Name]

Organic Consumers Association is a tax-exempt, non-profit organization, under the section 501(c)(3) of the Internal Revenue Code. All charitable donations are deductible to the full extent allowed by law.
EIN: 41-1908341

Donate • Privacy Policy • Contact

Designed with ♥ by 4Site Studios